Putting a New Spin on FT-MS

Courtesy of Thermo Finnigan Mass spectrometers that combine the high resolution and mass accuracy of Fourier transform mass spectrometry (FT-MS) with the ion storage and separation capabilities of quadrupole-quadrupole (Q-q) and linear ion trap mass spectrometry were recently introduced by Bruker Daltonics of Billerica, Mass., and Thermo Finnigan of San Jose, Calif. These instruments could accelerate the pace of protein identification in the rapidly expanding field of proteomics. FT-MS is bas

Written byAileen Constans
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Mass spectrometers that combine the high resolution and mass accuracy of Fourier transform mass spectrometry (FT-MS) with the ion storage and separation capabilities of quadrupole-quadrupole (Q-q) and linear ion trap mass spectrometry were recently introduced by Bruker Daltonics of Billerica, Mass., and Thermo Finnigan of San Jose, Calif. These instruments could accelerate the pace of protein identification in the rapidly expanding field of proteomics.

FT-MS is based on ion cyclotron resonance (ICR), in which ions generated by electrospray ionization or other methods are stored in an ICR cell in the presence of a magnetic field. The stored ions are excited with a radio frequency (RF) pulse, resulting in a cyclical motion with a frequency inversely proportional to the ions' mass-to-charge (m/z) ratio. The excited ions generate an image current that is then detected. Since each ion has a different frequency, the detected signal is a collection of the frequency components ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies